These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22315228)

  • 1. Lack of plakoglobin in epidermis leads to keratoderma.
    Li D; Zhang W; Liu Y; Haneline LS; Shou W
    J Biol Chem; 2012 Mar; 287(13):10435-10443. PubMed ID: 22315228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of Naxos plakoglobin levels restores cardiac function in mice.
    Zhang Z; Stroud MJ; Zhang J; Fang X; Ouyang K; Kimura K; Mu Y; Dalton ND; Gu Y; Bradford WH; Peterson KL; Cheng H; Zhou X; Chen J
    J Clin Invest; 2015 Apr; 125(4):1708-12. PubMed ID: 25705887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.
    Li D; Liu Y; Maruyama M; Zhu W; Chen H; Zhang W; Reuter S; Lin SF; Haneline LS; Field LJ; Chen PS; Shou W
    Hum Mol Genet; 2011 Dec; 20(23):4582-96. PubMed ID: 21880664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations with pathogenic potential in proteins located in or at the composite junctions of the intercalated disk connecting mammalian cardiomyocytes: a reference thesaurus for arrhythmogenic cardiomyopathies and for Naxos and Carvajal diseases.
    Rickelt S; Pieperhoff S
    Cell Tissue Res; 2012 May; 348(2):325-33. PubMed ID: 22450909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).
    McKoy G; Protonotarios N; Crosby A; Tsatsopoulou A; Anastasakis A; Coonar A; Norman M; Baboonian C; Jeffery S; McKenna WJ
    Lancet; 2000 Jun; 355(9221):2119-24. PubMed ID: 10902626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms.
    Rasmussen TB; Hansen J; Nissen PH; Palmfeldt J; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Sørensen KE; Baandrup UT; Bross P; Mogensen J
    Clin Genet; 2013 Jul; 84(1):20-30. PubMed ID: 23137101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel founder mutation in French-Canadian families with Naxos disease.
    Marino TC; Maranda B; Leblanc J; Pratte A; Barabas M; Dupéré A; Lévesque S
    Clin Genet; 2017 Oct; 92(4):451-453. PubMed ID: 28098346
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.
    Li J; Swope D; Raess N; Cheng L; Muller EJ; Radice GL
    Mol Cell Biol; 2011 Mar; 31(6):1134-44. PubMed ID: 21245375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naxos disease: from the origin to today.
    Li GL; Saguner AM; Fontaine GH
    Orphanet J Rare Dis; 2018 May; 13(1):74. PubMed ID: 29747658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Petrified" right ventricle in long-standing naxos arrhythmogenic right ventricular cardiomyopathy.
    Basso C; Tsatsopoulou A; Thiene G; Anastasakis A; Valente M; Protonotarios N
    Circulation; 2001 Dec; 104(23):E132-3. PubMed ID: 11733410
    [No Abstract]   [Full Text] [Related]  

  • 11. A Rare Cause of Syncope: Naxos Disease Caused by Novel Homozygous Deletion in the
    Sonsöz MR; İli EG; Gezdirici A; Topel C; Kahveci G; Bornaun H
    Circ Cardiovasc Imaging; 2021 Oct; 14(10):e013059. PubMed ID: 34587761
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of palmoplantar keratoderma and hair shaft anomalies, the warning signal of severe arrhythmogenic cardiomyopathy: a systematic review on genetic desmosomal diseases.
    Polivka L; Bodemer C; Hadj-Rabia S
    J Med Genet; 2016 May; 53(5):289-95. PubMed ID: 26399581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report of a Spanish patient with arrhythmogenic right ventricular cardiomyopathy and palmoplantar keratoderma without plakoglobin and desmoplakin gene modifications.
    Alonso-Orgaz S; Zamorano-León JJ; Fernandez-Arquero M; Villacastín J; Perez-Castellanos N; García-Torrent MJ; Macaya C; López Farré AJ
    Int J Cardiol; 2007 May; 118(2):275-7. PubMed ID: 17045679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naxos disease: a rare occurrence of cardiomyopathy with woolly hair and palmoplantar keratoderma.
    Rai R; Ramachandran B; Sundaram VS; Rajendren G; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2008; 74(1):50-2. PubMed ID: 18187826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When rare illuminates common: how cardiocutaneous syndromes transformed our perspective on arrhythmogenic cardiomyopathy.
    Sen-Chowdhry S; McKenna WJ
    Cell Commun Adhes; 2014 Feb; 21(1):3-11. PubMed ID: 24460197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of TUFT1, a Desmosome-Associated Protein, Causes Skin Fragility, Woolly Hair, and Palmoplantar Keratoderma.
    Verkerk AJMH; Andrei D; Vermeer MCSC; Kramer D; Schouten M; Arp P; Verlouw JAM; Pas HH; Meijer HJ; van der Molen M; Oberdorf-Maass S; Nijenhuis M; Romero-Herrera PH; Hoes MF; Bremer J; Slotman JA; van den Akker PC; Diercks GFH; Giepmans BNG; Stoop H; Saris JJ; van den Ouweland AMW; Willemsen R; Hublin JJ; Dean MC; Hoogeboom AJM; Silljé HHW; Uitterlinden AG; van der Meer P; Bolling MC
    J Invest Dermatol; 2024 Feb; 144(2):284-295.e16. PubMed ID: 37716648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new hypo/oligodontia syndrome: Carvajal/Naxos syndrome secondary to desmoplakin-dominant mutations.
    Chalabreysse L; Senni F; Bruyère P; Aime B; Ollagnier C; Bozio A; Bouvagnet P
    J Dent Res; 2011 Jan; 90(1):58-64. PubMed ID: 20940358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease).
    Kaplan SR; Gard JJ; Protonotarios N; Tsatsopoulou A; Spiliopoulou C; Anastasakis A; Squarcioni CP; McKenna WJ; Thiene G; Basso C; Brousse N; Fontaine G; Saffitz JE
    Heart Rhythm; 2004 May; 1(1):3-11. PubMed ID: 15851108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Syrris P; Wichter T; Matthias P; Saffitz JE; McKenna WJ
    Am J Hum Genet; 2007 Nov; 81(5):964-73. PubMed ID: 17924338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling of cell-cell junctions in arrhythmogenic cardiomyopathy.
    Asimaki A; Saffitz JE
    Cell Commun Adhes; 2014 Feb; 21(1):13-23. PubMed ID: 24460198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.